EASTERN MAINE MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1892-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.emmc.org/
Clinical Trials
5
Active:0
Completed:4
Trial Phases
2 Phases
Phase 4:3
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (60.0%)Not Applicable
2 (40.0%)Micronutrients as Adjunctive Treatment for Bipolar Disorder
Not Applicable
- Conditions
- Bipolar Disorder
- First Posted Date
- 2018-05-30
- Last Posted Date
- 2018-07-13
- Lead Sponsor
- Eastern Maine Medical Center
- Target Recruit Count
- 120
- Registration Number
- NCT03541031
- Locations
- 🇺🇸
Eastern Maine Medical Center, Bangor, Maine, United States
Clinical Trial Comparing Tranexamic Acid (TXA) With Aquamantys Sealer in Total Knee Arthroplasty (TKA)
Phase 4
Completed
- Conditions
- Blood Loss
- Interventions
- First Posted Date
- 2015-02-27
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- Eastern Maine Medical Center
- Target Recruit Count
- 127
- Registration Number
- NCT02374398
- Locations
- 🇺🇸
Eastern Maine Medical Center, Bangor, Maine, United States
Comparing Femoral Nerve Catheters to Single Shot Femoral Nerve Blocks for Total Knee Replacement Surgery
Not Applicable
Completed
- Conditions
- Knee Osteoarthritis
- Interventions
- Drug: Femoral Nerve CathetersDrug: Single Shot Femoral Nerve Blocks
- First Posted Date
- 2014-04-08
- Last Posted Date
- 2016-08-03
- Lead Sponsor
- Eastern Maine Medical Center
- Target Recruit Count
- 99
- Registration Number
- NCT02106481
- Locations
- 🇺🇸
Eastern Maine Medical Center, Bangor, Maine, United States
Comparison Between Methadone and Morphine for Neonatal Opiate Withdrawal
- First Posted Date
- 2013-03-05
- Last Posted Date
- 2017-09-28
- Lead Sponsor
- Eastern Maine Medical Center
- Target Recruit Count
- 31
- Registration Number
- NCT01804075
Treatment of Neonatal Abstinence Syndrome
Phase 4
Completed
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- Drug: Diluted Deodorized Tincture of Opium
- First Posted Date
- 2012-11-08
- Last Posted Date
- 2013-11-27
- Lead Sponsor
- Eastern Maine Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT01723722
- Locations
- 🇺🇸
Eastern Maine Medical Center, Bangor, Maine, United States
News
No news found